RA’ANANA, Israel, April 16, 2026 (GLOBE NEWSWIRE) — Inspira™ Applied sciences OXY B.H.N. Ltd. (Nasdaq: IINN) (“Inspira” or the “Company”), right now introduced the profitable supply and acceptance of an Additively Manufactured Electronics (“AME”) system at a Tier-1 U.S. protection buyer website below a industrial settlement.
The shopper website operates inside a broader ecosystem of strategic protection initiatives, together with quantum computing, quantum networking, built-in photonics, and superconducting techniques. Advancing these subtle fields requires overcoming crucial {hardware} bottlenecks, notably concerning advanced part integration and excessive miniaturization.
Inspira’s AME platform is purposefully constructed for these constraints, enabling the speedy fabrication of extremely built-in digital buildings with ultra-compact architectures and geometries which can be tough or unattainable to attain via customary processes. The engagement consists of ongoing provide of proprietary consumables and supplies, establishing a contractual basis for recurring income past the preliminary system sale, with further income potential from application-specific diversifications because the buyer’s utilization scales.
“We view this deployment as a representation of the tangible commercial execution of our AME strategy in an advanced customer environment,” stated Dagi Ben-Midday, Chief Govt Officer of Inspira. “This milestone confirms the commercial demand for our AME platform in top-tier defense operations and may serve as a powerful catalyst for our accelerating financial momentum and growth.”
The shopper’s id and particular transaction phrases should not being disclosed, in accordance with confidentiality necessities that are customary for engagements with U.S. protection entities of this profile.
More Read
About Inspira TechnologiesInspira Applied sciences OXY B.H.N. Ltd. (Nasdaq: IINN, IINNW) is a know-how firm targeted on fixing probably the most crucial bodily and {hardware} bottlenecks in quantum computing connectivity. Inspira develops distinctive quantum connectivity options designed for high-density, thermally optimized operation in dilution cryostats, a prerequisite for scaling quantum techniques past present bodily limitations. Moreover, the Firm continues to advance its medical know-how portfolio, together with its respiratory assist and blood monitoring platforms below a devoted enterprise unit. For extra data, please go to: www.q-trex.com and www.inspira-technologies.com
Ahead-Trying Assertion DisclaimerThis press launch comprises categorical or implied forward-looking statements pursuant to U.S. Federal securities legal guidelines. These forward-looking statements are based mostly on the present expectations of the administration of the Firm solely and are topic to a lot of elements and uncertainties that might trigger precise outcomes to vary materially from these described within the forward-looking statements. For instance, the Firm is utilizing forward-looking statements when it discusses its AME platform’s skill to beat constraints and allow speedy fabrication of extremely built-in digital buildings with ultra-compact architectures and geometries; its skill to provide proprietary consumables and supplies as a part of the engagement; its skill to establishing a contractual basis for recurring income past the preliminary system sale; the extra income potential from application-specific diversifications because the buyer’s utilization scales; and that the milestone confirms the industrial demand for its AME platform in top-tier protection operations and serves as a strong catalyst for its accelerating monetary momentum and progress. These forward-looking statements and their implications are based mostly solely on the present expectations of the Firm’s administration and are topic to a lot of elements and uncertainties that might trigger precise outcomes to vary materially from these described within the forward-looking statements. Besides as in any other case required by regulation, the Firm undertakes no obligation to publicly launch any revisions to those forward-looking statements to replicate occasions or circumstances after the date hereof or to replicate the prevalence of unanticipated occasions. Extra detailed details about the dangers and uncertainties affecting the Firm is contained below the heading “Risk Factors” within the Firm’s annual report on Kind 20-F for the fiscal yr ended December 31, 2025, filed with the U.S. Securities and Alternate Fee (the “SEC”), which is obtainable on the SEC’s web site at www.sec.gov.
